European equities rallied on Thursday, closing nearly 1 percent higher as investors reacted to a raft of corporate earnings and fresh economic data.» Read More
Marijn Dekkers, CEO of Bayer, says the company does not feel the "absolute need" to make acquisitions, but is keeping an eye on opportunities in the market.
"Smiling from a safe distance" is how German media described China's President Xi Jinping during his press conference last Friday.
European stock markets trimmed last week's gains to close lower on Monday, off the back of weak Chinese data and tensions in Ukraine.
European stocks closed flat on Friday, boosted by economic data from the U.S.
German pharmaceutical group Bayer offered to buy Norway's Algeta for $2.4 billion, Algeta said on Tuesday.
A majority of women are unaware birth control is available for free from health insurance plans under Obamacare, although that right faces court challenges.
We could be witnessing the beginning of a merger wave in biotech, Jim Cramer said Tuesday.
Amgen has struck a $10 billion-plus deal to buy Onyx Pharmaceuticals, ending a two-month-long auction for the cancer drugmaker.
Marijn Dekkers, CEO of drug and chemicals company Bayer, tells CNBC that falling earnings in the material sciences division may make it harder to achieve its earnings goals for the year.
China is preventing a GlaxoSmithKline executive from leaving the country as police accuse the British drugmaker of bribing officials and doctors, the drugmaker says.
A federal judge in Kansas City, Kansas, ordered Dow Chemical Co on Wednesday to pay $1.2 billion in a price-fixing case involving chemicals used to make foam products in cars.
European shares closed higher on Monday after Italy's new Prime Minister announced his reform plans in his maiden speech to parliament.
Germany's Bayer has agreed to buy U.S. contraceptive devices maker Conceptus for $1.1 billion, aiming to underpin its position as the world's largest women's healthcare provider.
Marijn Dekkers, CEO of Bayer, says the positive outlook for 2013 is driven by strong projected strong growth in Healthcare and Crop Sciences and explains how the company is heavily investing in its growth.
Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country with a market potential as large as India's.
Marijn Dekkers, CEO of Bayer, tells CNBC why the company's development of new drugs make him confident of reaching targets set of 2.5 billion euros in drug sales.
Syngenta, the world's largest agrochemicals company, said it was confident ahead of the upcoming planting season and will hike its dividend 19 percent after it posted a full-year net profit that beat expectations.
Weak GDP data for the U.K. wasn't enough to stop European shares rising on Friday as Germany's DAX Index reached a level not seen since January 2008 after business climate data was released.
Marijn Dekkers, CEO of Bayer, talks to CNBC about the outlook for the pharmaceutical industry
The big U.S. and European drug companies are dealing with their own 'cliff' as blockbuster drugs lose their patent protection. But they are turning back to research and development to fill the gap.